Gut mucosa alterations after kidney transplantation: a cross sectional study

Rashmi Joshi1, Carmine Secondulfo2, Alessandro Caputo3

  • 1Department of Translational Medical Sciences, University of Campania, Via Pansini, 5, 80131, Naples, Italy.

Journal of Nephrology
|September 17, 2024
PubMed
Abstract

Insights

Kidney transplant recipients on mycophenolate show increased interstitial cells in the colon, leading to subtle gland architectural changes. This study clarifies immunosuppressant effects on the gut, distinct from cancer risk.

Area of Science:

  • Gastroenterology
  • Transplant Medicine
  • Oncology

Background:

  • Kidney transplant recipients (KTRs) use immunosuppressants like mycophenolate, which can cause intestinal issues and inflammation.
  • While KTRs have higher skin cancer risk, colorectal cancer risk is not elevated.
  • Understanding colon histological changes in KTRs may reveal immunosuppressant impacts on cancer development.

Purpose of the Study:

  • To investigate histological alterations in the colon of KTRs.
  • To compare colon changes in KTRs with known skin alterations.
  • To understand how immunosuppressants influence cancer development and progression.

Main Methods:

  • Analysis of whole slide images from gut biopsies of KTRs (n=49) and non-transplanted subjects (n=35).
  • Utilized ImageJ and R programming for quantitative analysis of epithelial, interstitial, mitotic, and endothelial cells.
  • Examined 1788 glands to assess inflammatory milieu changes in KTRs and cancer patients.

Main Results:

  • KTRs without colon cancer exhibited significantly higher interstitial cell density compared to controls.
  • Increased interstitial cells correlated with subtle colon gland architectural modifications, not epithelial cell density changes.
  • No significant structural differences in cancer samples were found between KTRs and non-transplanted patients.

Conclusions:

  • KTRs treated with mycophenolate display an increased number of resident interstitial cells in the colon.
  • These cellular changes are linked to subtle alterations in colon gland architecture.
  • Findings contribute to understanding immunosuppressant-induced colonic changes.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...